Virginia Ruth Sanzone - 10 Sep 2021 Form 4 Insider Report for ICU MEDICAL INC/DE (ICUI)

Signature
By: Paula Darbyshire, Attorney-in-fact For: Virginia Sanzone
Issuer symbol
ICUI
Transactions as of
10 Sep 2021
Net transactions value
-$201,241
Form type
4
Filing time
13 Sep 2021, 11:46:36 UTC
Previous filing
12 May 2021
Next filing
08 Mar 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICUI Common Stock Sale $37,785 -151 -6.3% $250.23 2,254 10 Sep 2021 Direct F1
transaction ICUI Common Stock Sale $100,757 -401 -18% $251.27 1,853 10 Sep 2021 Direct F2
transaction ICUI Common Stock Sale $62,698 -248 -13% $252.82 1,605 10 Sep 2021 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $249.76 to $250.72, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.88 to $251.83, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.23 to $253.05, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.